Cell Culture – News and Features

Discover a simple, automated method of producing many lung organoids at once, open the door for more effective ways to trial lung disease and cancer treatments.

Automated lung organoid production offers scalable, human-based models for testing therapies and accelerating lung disease research.

Using human iPSC-derived kidney organoids, researchers showed that NPHP1 deficiency triggers abnormal Hippo signaling that accelerates fibrosis in nephronophthisis. The model reproduced disease-specific scarring not seen in animals.

Researchers have developed a calcium-activated delivery system that improves how antibody–drug conjugates penetrate tumor cells.

Where do the greatest opportunities for collaboration across life sciences disciplines lie today – and what’s needed to unlock them? We asked the experts.

This article examines some of the cell-based approaches that researchers are using to study acquired drug resistance and the effects of specific genetic variants on cancer cell physiology.

New research has identified that major depressive disorder is deeply connected to the immune system.

Researchers at the University of California San Diego School of Medicine have identified a promising new therapy for triple-negative breast cancer (TNBC), which is among the most aggressive and difficult-to-treat forms of the disease.

In this article, ReiThera's scientific and operational leaders discuss ReiThera’s proprietary platforms, process development strategy and its evolving role as a CDMO partner in the advanced therapies landscape.

A naturally occurring protein, FGD3, has been shown to boost the effectiveness of chemotherapies and immunotherapies by rupturing cancer cells disrupted by these drugs.